SANUWAVE Health, Inc. announced that it has entered into a Securities Purchase Agreement with the purchasers to issue convertible promissory notes for the gross proceeds of $1,800,000 on December 30, 2023. The principal amount of the notes is $1,900,000 and warrants to purchase an additional 46,500,000 shares of common stock with an exercise price of $0.067 per share and warrants to purchase an additional 46,500,000 shares of common stock with an exercise price of $0.04 per share. The Warrants have a five-year term. At the Closing Date, the Company received total proceeds of $1,800,000. The notes are converted at a conversion price of $0.04 per share. The securities in the Private Placement were offered and sold in a transaction exempt from registration under the Securities Act in reliance on Section 4(a)(2) thereof. Each Purchaser represented that it was an accredited investor.

The company has raised $1,861,250 pursuant to Regulation D from 15 investors.